Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCDate | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
---|---|---|---|---|
6/30/2025 | $ 4.32M | $ 69.81M | $ 416.81M | $ 351.32M |
3/31/2025 | $ 2.78M | $ 69M | $ 483.16M | $ 416.93M |
12/31/2024 | $ 2.17M | $ 67.44M | $ 385.14M | $ 319.87M |
9/30/2024 | $ 2.94M | $ 58.34M | $ 464.09M | $ 408.7M |
6/30/2024 | $ 2.88M | $ 55.57M | $ 427.16M | $ 374.47M |
3/31/2024 | $ 2.48M | $ 49.08M | $ 636.19M | $ 589.59M |
12/31/2023 | $ 2.13M | $ 45.56M | $ 711.01M | $ 667.57M |
9/30/2023 | $ 6.1M | $ 37.44M | $ 1.06B | $ 1.03B |
6/30/2023 | $ 1.42M | $ 30.76M | $ 589.87M | $ 560.54M |
3/31/2023 | $ 6.19M | $ 31.36M | $ 658.76M | $ 633.59M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap + Debt - CashnEq
(=) EV
EV for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.11B ] + Debt [ $ 23.77M ] - CashnEq [ $ 9.25M ]
(=) EV [ $ 1.13B ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.33K |
---|---|
min | $ -1.69B |
max | $ 6.81B |
average | $ 1.25B |
median | $ 438.06M |
std | $ 1.66B |